BN

Brian Naber

Director Director DIN 09115300
DIN 09115300 First appointment Apr 2021 Primary industry Agriculture
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Apr 2021
Shareholding value •••• Premium profile

About Brian Naber

Data last updated:

Brian Naber was a Director at Bayer Cropscience Limited (2022–2024) and Director at Bayer Vapi Private Limited (2021–2022). The companies operate in Agriculture.

DIN 09115300
Primary Designation Director
Industry Agriculture
First Appointment 01 Apr 2021

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Bayer Cropscience Limited L24210MH1958PLC011173
Director01 Jan 20221958₹5,593 Cr (FY 2025)Active
Bayer Vapi Private Limited U99999GJ1990PTC049322
Director01 Apr 20211990₹2,200 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Bayer Cropscience Limited
Bayer Vapi Private Limited
Premium access

Shareholding and investment profile for Brian Naber

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Brian Naber

Brian Naber was first appointed on 01 Apr 2021 as Director at Bayer Vapi Private Limited. The most recent appointment on record is 01 Jan 2022 at Bayer Cropscience Limited.

Brian Naber held 2 earlier board appointments: Bayer Cropscience Limited (Director, 01 Jan 2022 to 01 Feb 2024); Bayer Vapi Private Limited (Director, 01 Apr 2021 to 14 Mar 2022).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available